Procept   Report issue

For profit Phase 1 Phase 3 Phase 4
Founded: Redwood Shores CA United States (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2000

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (5)

Key: Procept (0) Acquired (5)

bismuth (1 trial)

metronidazole (flagyl) (1 trial)

pantoprazole (protonix) (1 trial)

ramipril (altace) (1 trial)

tetracycline (tetrex) (1 trial)

Drugs in Phase 3 Trials (1)

Key: Procept (0) Acquired (1)

rimabotulinumtoxinB (Myobloc) (1 trial)

Drugs in Phase 1 Trials (1)

tenofovir (viread) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 7